Determination of Advanced Glycation End Products in Serum by Fluorescence Spectroscopy and Competitive ELISA

Clinical Chemistry and Laboratory Medicine

Volumn 35, Issue 9, 1997, Pages 669-678

  Münch, Gerald ^a   Keis, Regina ^a   Weβels, Andrea ^a   Riederer, Peter ^a   Bahner, Udo ^a   Heidland, August ^a   Niwa, Toshimitsu ^a   Lemke, Horst Dieter ^a   Schinzel, Reinhard ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; HETEROCYCLIC COMPOUND; IMIDAZOLE; KEYHOLE LIMPET HEMOCYANIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ADULT; AGED; AGING; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE SPECTROSCOPY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION;

AGED; ANTIBODIES, MONOCLONAL; ARGININE; BINDING, COMPETITIVE; CHROMATOGRAPHY, GEL; DEOXYGLUCOSE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOCYANIN; HEMOGLOBINS; HUMANS; IMIDAZOLES; MOLECULAR WEIGHT; RENAL DIALYSIS; SPECTROMETRY, FLUORESCENCE; STATISTICS;

EID: 0030698699     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.1997.35.9.669     Document Type: Article

References (34)

1. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995; 46: 223-234.
2. Monnier VM, Cerami A. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 1981; 211: 491-493.
3. Niwa T, Katsuzaki T, Miyazaki S, Momoi T, Akiba T, Miyazaki T, et al. Amyloid beta(2)-microglobulin is modified with imi-dazolone, a novel advanced glycation end product, in dialysis-related amyloidosis. Kidney Int 1997; 51: 187-194.
4. Monnier VM, Nagaraj RH, Porterootin M, Glomb M, Elgawish AH, Sell DR, et al. Structure of advanced Maillard reaction products and their pathological role. Nephrol Dial Transplant 1996; 11 Supplement 5: 20-26.
5. Odetti P, Pronzato MA, Noberasco G, Cosso L, Traverso N, Cottalasso D, et al. Relationships between glycation and oxidation related fluorescences in rat collagen during aging - an in vivo and in vitro study. Lab Invest 1994; 70: 61-67.
6. Vlassara H, Bucala R, Striker L. Biology of disease. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994; 70: 138-151.
7. Friedlander MA, Wu YC, Schulak JA, Monnier VM, Hricik DE, Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease. Am J Kidney Dis 1995; 25: 445-451.
8. Gerbitz KD, Dolhofer-Bliesener R, Lechner B, Deppisch R, Ritz E. Immunological determination of advanced glycation endproducts in human blood and urine. Nephrol Dial Transplant 1995; 10: 654-657.
9. Gerbitz KD, Dolhofer-Bliesener R, Lechner B. Possible significance of advanced glycation end products in serum in endstage renal disease and in complications of diabetes. Eur J Clin Chem Clin Biochem 1996, 34: 355-361.
10. Münch G, Double K, Schinzel R, Riederer R Advanced glycation endproducts and oxidative stress - a vicious circle in neurodegeneration? Alzheimer's Dis Rev 1996; 1: 71-74.
11. Bucala R, Cerami A. Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv Pharmacol 1992; 23: 1-34.
12. Smith MA, Sayre LM, Monnier VM, Perry G. Radical AGEing in Alzheimer's disease. Trends Neurosci 1995; 18: 172-176.
13. Palinski W, Koschinsky T, Butler SW, Miller E, Vlassara H, Cerami A, et al. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. Arterioscler Thromb Vase Biol 1995; 15: 571-582.
14. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 1995; 96: 1395-1403.
15. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sei USA 1994; 91 Supplement 24: 11704-11708.
16. Papanastasiou P, Grass L, Rodela H, Patrikarea A, Oreopoulos D, Diamandis EP, Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int 1994; 46: 216-222.
17. Deutscher MP, editor. Guide to protein purification. San Diego: Academic Press, 1990.
18. Fairbanks VF, Klee GG, Biochemical aspects of hematology. In: Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistry. Philadelphia: Saunders, 1994: 1974-2072.
19. Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW, N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 1995; 34: 10872-10878.
20. Ideda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, Araki T, et al. N-epsilon-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 1996; 35: 8075-8083.
21. Chio KS, Tappel AL, Synthesis and characterization of the fluorescent products derived from malonaldehyde and amino acids. Biochemistry 1969; 8: 2821-2826.
22. Wickens DG, Norden AG, Lunec J, Dormandy TL, Fluorescence changes in human gamma-globulin induced by free-radical activity. Biochim Biophys Acta 1983; 742: 607-616.
23. Miyata T, Maeda K, Rurokawa K, Destrihou CV, Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Nephrology, Dialysis, Transplantation 1997; 12: 255-258.
24. Nguyenkhoa T, Nguyen NT, Zingraff J, Jüngers P, Descampslatscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304-1313.
25. Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufman AM, Korbet SM, Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet 1994; 343: 1519-1522.
26. Smith MA, Taneda S, Richey PL, Miyata S, Yan SD, Stem D, et al. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sei USA 1994; 91: 5710-5714.
27. Monnier VM, Sell DR, Miyata S, Nagaraj RH, Odetti P, Lapolla A. Advanced Maillard reaction products as markers for tissue damage in diabetes and uraemia - relevance to diabetic nephropathy Acta Diabetol 1992; 29: 130-135.
28. Niwa T, Sato M, Katsuzaki T, Tomoo T, Miyazaki T, Tatemichi N, et al. Amyloid beta(2)-microglobulin is modified with N-epsilon-(carboxymethyl)lysine in dialysis-related amyloidosis. Kidney Int 1996; 50: 1303-1309.
29. Bellmunt MJ, Portero M, Pamplona R, Muntaner M, Prat J. Age-related fluorescence in rat lung collagen Lung 1995; 173: 177-185.
30. Obayashi H, Nakano K, Shigeta H, Xamaguchi M, Yoshimori K, Fukui M, et al. Formation of crosslinks as a fluorescent advanced glycation end product in vitro and in vivo. Biochem Biophys Res Commun 1996; 226: 37-41.
31. Friedlander MA, Wu YC, Elgawish A, Monier VM, Early and advanced glycosylation end products - kinetics of formation and clearance in peritoneal dialysis. J Clin Invest 1996; 97: 728-735.
32. Yin DZ, Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. Free Rad Biol Med 1996; 21: 871-888.
33. Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 1990; 173: 932-939.
34. Odetti P, Traverso N, Cosso L, Noberasco G, Pronzato MA, Marinari UM: Good glycaemic control reduces oxidation and glycation end-products in collagen of diabetic rats. Diabeto-logia 1996; 39: 1440-1447.